<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>Antibody Drug Conjugate &#8211; Global Market Studies</title>
	<atom:link href="https://www.globalmarketstudies.com/tag/antibody-drug-conjugate/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.globalmarketstudies.com</link>
	<description>Global Market Studies</description>
	<lastBuildDate>Tue, 22 Aug 2023 06:11:30 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.2</generator>

<image>
	<url>https://www.globalmarketstudies.com/wp-content/uploads/2019/06/favicon-01-100x100.png</url>
	<title>Antibody Drug Conjugate &#8211; Global Market Studies</title>
	<link>https://www.globalmarketstudies.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>The Antibody-Drug Conjugates Market: Key Players, Innovations, and Future Prospects</title>
		<link>https://www.globalmarketstudies.com/antibody-drug-conjugates-market-future-prospects/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 08 Aug 2023 10:19:48 +0000</pubDate>
				<category><![CDATA[market research]]></category>
		<category><![CDATA[Antibody Drug Conjugate]]></category>
		<category><![CDATA[healthacre]]></category>
		<category><![CDATA[healthcare industry]]></category>
		<guid isPermaLink="false">https://www.globalmarketstudies.com/?p=17152</guid>

					<description><![CDATA[Antibody Drug Conjugates Market Trends And Future Forecast For 2023 To 2028 A recent study by Global Market Studies has shown that the Antibody Drug Conjugates Market is rapidly growing at a CAGR  of 26.7% and is expected to reach a value of USD 20.64 billion by 2028. The antibody-drug conjugates (ADCs) market refers to the pharmaceuticals market for a class of targeted cancer therapies that use monoclonal antibodies to&#8230;]]></description>
		
		
		
			</item>
	</channel>
</rss>
